Primary Effectiveness Sample Clauses

Primary Effectiveness. The primary objective of this study is to evaluate the overall performance of DD T2 lenses when compared to Oasys 1-Day, MyDay and 1-Day Acuvue Moist. The primary endpoint is the subjective rating on overall quality of vision, collected binocularly on a scale of 1 (Poor) to 10 (Excellent).
View SourceView Similar (2)
Primary Effectiveness. The primary objective of this study is to evaluate the overall performance of an investigational silicone hydrogel contact lens over 2 weeks of daily wear. The primary endpoint is front surface wettability, collected on a 5-point scale, for each eye.
View SourceView Similar (2)
Primary Effectiveness. The primary objective of this study is to explore overall vision with BIOFINITY ENERGYS as compared to BIOFINITY lenses after 1 week of wear. The primary endpoint is the subjective rating of overall vision, collected binocularly on a scale of 1 (Poor) to 10 (Excellent).
View Source
Primary Effectiveness. The primary objective of this study is to evaluate the overall performance of an investigational silicone hydrogel lens when compared to AOHP. The primary endpoint is distance VA with study lenses, collected in logMAR, for each eye.
View Source
Primary Effectiveness. ‌ The primary objective of this study is to evaluate the clinical performance of an investigational frequent replacement daily wear SiHy sphere contact lens, , over 7 days of daily wear. The primary endpoint is front surface wettability, collected on a 5-point scale, for each eye.
View Source
Primary Effectiveness. The primary objective of this study is to evaluate corneal staining observed after 2 hours of wear with LID018869 against both PureVision, pre-cycled with Biotrue, and Biofinity lenses, pre-cycled with Replenish. The primary endpoint is the average of corneal staining areas observed (expressed as a percent) taken over the 5 regions: central, superior, nasal, inferior, and temporal, after 2 hours of lens wear.
View Source
Primary Effectiveness. The primary objective of this study is to evaluate the overall performance of PRECISION1 contact lenses when compared to INFUSE contact lenses. The primary endpoint is distance VA with study lenses, collected in logMAR, for each eye.
View Source
Primary Effectiveness. The primary objective of this study is to evaluate VA after approximately 4 weeks of lens wear. The primary endpoint is distance VA with study lenses, collected in Snellen at the 4-week follow-up visit, for each eye. Conversion will be made to the logMAR scale.
View Source

Related to Primary Effectiveness

  • Integration; Effectiveness This Agreement, the other Loan Documents, and any separate letter agreements with respect to fees payable to the Administrative Agent or any L/C Issuer, constitute the entire contract among the parties relating to the subject matter hereof and supersede any and all previous agreements and understandings, oral or written, relating to the subject matter hereof. Except as provided in Section 4.01, this Agreement shall become effective when it shall have been executed by the Administrative Agent and when the Administrative Agent shall have received counterparts hereof that, when taken together, bear the signatures of each of the other parties hereto, and thereafter shall be binding upon and inure to the benefit of the parties hereto and their respective successors and assigns.

  • Effectiveness This Agreement shall become effective upon the execution and delivery hereof by the parties hereto.

  • Termination Effectiveness This Agreement and the Proxy shall terminate and shall have no further force or effect as of the Expiration Date. Notwithstanding the foregoing, nothing set forth in this Section 11 or elsewhere in this Agreement shall relieve either party hereto from any liability, or otherwise limit the liability of either party hereto, for any breach of this Agreement. The effectiveness of this Agreement is conditioned upon the execution and delivery of the Merger Agreement by the parties thereto.

  • Counterparts; Integration; Effectiveness This Agreement may be executed in counterparts (and by different parties hereto in different counterparts), each of which shall constitute an original, but all of which when taken together shall constitute a single contract. This Agreement and the other Loan Documents constitute the entire contract among the parties relating to the subject matter hereof and supersede any and all previous agreements and understandings, oral or written, relating to the subject matter hereof. Except as provided in Section 4.01, this Agreement shall become effective when it shall have been executed by the Administrative Agent and when the Administrative Agent shall have received counterparts hereof that, when taken together, bear the signatures of each of the other parties hereto. Delivery of an executed counterpart of a signature page of this Agreement by telecopy or other electronic imaging means shall be effective as delivery of a manually executed counterpart of this Agreement.

  • Filing and Effectiveness The Company shall file a Registration Statement relating to any Demand Registration as promptly as practicable, but in any event no later than sixty (60) days after receipt of a Demand Notice, with the SEC and use its reasonable best efforts to cause such Registration Statement to be declared effective as soon as practicable thereafter and to remain effective for a period of time reasonably required for the disposition of the Registrable Securities covered by such Registration Statement. If any Demand Registration is requested to be effected as a shelf registration pursuant to Rule 415 under the Securities Act by the Holders demanding such Demand Registration, the Company shall keep the Registration Statement filed in respect thereof effective for a period of six (6) months from the date on which the SEC declares such Registration Statement effective or such shorter period that will terminate when all Registrable Securities covered by such Registration Statement have been sold pursuant to such Registration Statement. The Company shall promptly, and in any event within ten (10) Business Days after receipt of a Demand Notice, notify all other Holders in writing of the receipt of such Demand Notice and each such other Holder shall have the right to have all or a part of such Holder’s Registrable Securities included in such registration thereof by delivering a written notice (a “Participating Notice”) to the Company within ten (10) Business Days after receipt of the aforementioned notice from the Company (each Holder that delivers a Participating Notice to the Company pursuant to this Section 3(b), a “Participating Demand Holder”). Each Participating Demand Holder shall specify in the Participating Notice the number of Registrable Securities that such Participating Demand Holder elects to include in such registration and the Company shall include in such registration all Registrable Securities requested by the Participating Demand Holders for inclusion as specified in the Participation Notices.